[{"id":"d67808ce-9871-4709-b216-0c4d3d564eb1","acronym":"","url":"https://clinicaltrials.gov/study/NCT05683717","created_at":"2023-01-13T15:59:31.133Z","updated_at":"2024-07-02T16:35:28.472Z","phase":"Phase 1","brief_title":"A Phase 1 Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies","source_id_and_acronym":"NCT05683717","lead_sponsor":"TransThera Sciences (Nanjing), Inc.","biomarkers":" CD20","pipe":"","alterations":" ","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TT-01488"],"overall_status":"Recruiting","enrollment":" Enrollment 37","initiation":"Initiation: 03/30/2023","start_date":" 03/30/2023","primary_txt":" Primary completion: 10/31/2026","primary_completion_date":" 10/31/2026","study_txt":" Completion: 10/30/2028","study_completion_date":" 10/30/2028","last_update_posted":"2023-11-21"}]